Back
Full-text
Journal article

Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology.

  • Zhang Y Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Coats AJS Department of Cardiology, IRCCS San Raffaele Pisana, Rome, Italy.
  • Zheng Z Department of Cardiovascular Surgery, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Adamo M Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Ambrosio G Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy.
  • Anker SD Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Butler J Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Xu D Key Laboratory for Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China.
  • Mao J First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Khan MS Department of Medicine, Cook County Hospital, Chicago, IL, USA.
  • Bai L Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Mebazaa A Université de Paris, Paris, France; U942 Inserm - MASCOT and Department of Anaesthesia and Critical Care, University Hospitals Saint Louis-Lariboisière, APHP, Paris, France.
  • Ponikowski P Center for Heart Diseases, University Hospital, Medical University, Wroclaw, Poland.
  • Tang Q Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, China.
  • Ruschitzka F University Heart Centre, University Hospital Zurich, Zurich, Switzerland.
  • Seferovic P Clinic of Endocrinology, Diabetes and Metabolic Diseases, Belgrade University Medical Center, Belgrade, Serbia.
  • Tschöpe C Department of Cardiology, Campus Virchow Klinikum, Charite - Universitaetsmedizin Berlin, Berlin, Germany.
  • Zhang S Department of Cardiology, Peking Union Medical College & Chinese Academy of Medical Science, Peking Union Medical College Hospital, Beijing, China.
  • Gao C Department of Cardiology, Henan Provincial People's Hospital, Fuwai Central China Cardiovascular Hospital, Zhengzhou, China.
  • Zhou S Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Senni M Cardiology Division, Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Zhang J Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Metra M Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Show more…
  • 2020-05-29
Published in:
  • European journal of heart failure. - 2020
COVID-19
Coronavirus
Diagnosis
Heart failure
Management
SARS-CoV-2
Betacoronavirus
Cardiology
China
Comorbidity
Coronavirus Infections
Disease Management
Europe
Heart Failure
Humans
Pandemics
Pneumonia, Viral
Societies, Medical
English The coronavirus disease 2019 (COVID-19) pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is causing considerable morbidity and mortality worldwide. Multiple reports have suggested that patients with heart failure (HF) are at a higher risk of severe disease and mortality with COVID-19. Moreover, evaluating and treating HF patients with comorbid COVID-19 represents a formidable clinical challenge as symptoms of both conditions may overlap and they may potentiate each other. Limited data exist regarding comprehensive management of HF patients with concomitant COVID-19. Since these issues pose serious new challenges for clinicians worldwide, HF specialists must develop a structured approach to the care of patients with COVID-19 and be included early in the care of these patients. Therefore, the Heart Failure Association of the European Society of Cardiology and the Chinese Heart Failure Association & National Heart Failure Committee conducted web-based meetings to discuss these unique clinical challenges and reach a consensus opinion to help providers worldwide deliver better patient care. The main objective of this position paper is to outline the management of HF patients with concomitant COVID-19 based on the available data and personal experiences of physicians from Asia, Europe and the United States.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/258352
Statistics
Document views: 7 File downloads:
  • fulltext.pdf: 0